Clinical Trials Directory

Trials / Completed

CompletedNCT03749512

NLCR in Prediction of the Grade of Lung Tumor.

Preoperative Neutrophil-lymphocyte Count Ratio in Prediction of the Grade of Lung Tumor.

Status
Completed
Phase
Study type
Observational
Enrollment
400 (actual)
Sponsor
Medical University of Silesia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to assess whether the value of neutrophil-lymphocyte count ratio from the routine preoperative blood test may predict lung tumors' grading.

Detailed description

Lung cancer remains as one of the leading causes of death among oncology patients. Close connection between inflammation and pathogenesis of some neoplasms was determined in a number of studies. Some studies show promise that ratio of neutrophil to lymphocyte count (NLCR) may be recognized as a prognostic marker for several carcinomas: renal, lung and colorectal. The aim of the study is to assess whether the value of neutrophil-lymphocyte count ratio from the routine preoperative blood test may predict lung tumors' grading. During routine preoperative blood tests complete blood count is done and NLCR, WBC, neutrophil and lymphocyte count is noted. After the thoracic surgery intervention and histopathological examination grading of lung tumor is noted.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTComplete blood countDuring routine preoperative blood test complete blood count is taken.
OTHERHistopathological examinationRoutine postoperative histopathological examination of lung tumor.

Timeline

Start date
2014-10-01
Primary completion
2018-10-15
Completion
2018-11-16
First posted
2018-11-21
Last updated
2018-11-21

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT03749512. Inclusion in this directory is not an endorsement.